Daniel Brickman
Oregon Health & Science University, Carolinas Healthcare System
Papers
4
Total Citations
156
H-Index
4
About
Daniel Brickman is a leading head and neck surgeon whose research focuses on optimizing surgical outcomes in transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. His work has fundamentally advanced our understanding of how to reduce complications and improve patient recovery in this minimally invasive approach. Brickman's landmark 2017 study on prophylactic external carotid artery ligation (73 citations) demonstrated a significant reduction in postoperative bleeding, establishing a new safety standard for TORS. He further transformed perioperative care through a randomized controlled trial showing that extended corticosteroid therapy dramatically improves pain control after robotic surgery (32 citations). His investigations into HPV-associated oropharyngeal cancer have identified key predictors of extracapsular extension (29 citations), helping surgeons better stratify risk and tailor treatment. Brickman's comprehensive review of robotic approaches to the pharynx (22 citations) remains an essential resource for surgeons adopting these techniques. Through rigorous clinical trials and outcomes research, Brickman has made TORS safer and more tolerable, directly improving the lives of patients with oropharyngeal cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robotic Approaches to the Pharynx22 citations · 2014